Pfizer Inc. buy BMO Capital Markets
Start price
02.08.23
/
50%
€32.40
Target price
02.08.24
€40.22
Performance (%)
-15.59%
End price
03.08.24
€27.35
Summary
This prediction ended on 03.08.24 with a price of €27.35. The prediction for Pfizer Inc. disappointed with a performance of -15.59%. BMO_Capital_Markets has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. Dividends of €1.93 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | 4.337% | 4.337% | 8.443% |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at BMO Capital Markets from $45.00 to $44.00. They now have an "outperform" rating on the stock.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten